New cancer treatment shows great hope on its first clinical trial in London. A drug name olaparib was given to 60  patients all of them with advanced breast cancer, ovarian cancer and prostate cancer and all of them had mutations in the BRCA1 and BRCA2 genes associated with inherited forms of these cancers. The treatment decreases tumors’ size and did not damage healthy cells.

Read the full story (The Financial Times)

1. Vincenzo Garrabrant Says:
   March 6th, 2010 at 23:01

   p.s. You have a very good template . Where did you find it?

You must be logged in to post a comment.